Activating mutations in ALK provide a therapeutic target in neuroblastoma

Rani E. George(Harvard University), Takaomi Sanda(Pediatric Oncology Group), Megan Hanna(Broad Institute), Stefan Fröhling(Harvard University), William Luther(Pediatric Oncology Group), Jianming Zhang(Harvard University), Yebin Ahn(Pediatric Oncology Group), Wenjun Zhou(Harvard University), Wendy B. London(University of Florida), Patrick McGrady(Children's Oncology Group), Liquan Xue, Sergey Zozulya(ChemBridge (United States)), V. Gregor(ChemBridge (United States)), Thomas R. Webb(St. Jude Children's Research Hospital), Nathanael S. Gray(Dana-Farber Cancer Institute), D. Gary Gilliland(Brigham and Women's Hospital), Lisa Diller(Pediatric Oncology Group), Heidi Greulich(Broad Institute), Stephan W. Morris, Matthew Meyerson(Broad Institute), A. Thomas Look(Pediatric Oncology Group)
Nature
October 1, 2008
10.1038/nature07397
Cited by 892Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis